Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
107.37 M TWD
1.22 B TWD
125.45 M
About Orient Pharma Co., Ltd.
Sector
Industry
CEO
Chun-Tong Huang
Website
Headquarters
Taipei
Founded
2008
ISIN
TW0004166004
FIGI
BBG0033966J0
Orient Pharma Co., Ltd. engages in the research, development, and production of pharmaceutical products. Its products include anti-psychotics, drugs for treating Alzheimer's disease, psychostimulants, and drugs for treating Parkinson's disease. The company was founded on February 1, 2008 and is headquartered in Taipei, Taiwan.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4166 is 24.20 TWD — it has increased by 1.65% in the past 24 hours. Watch Orient Pharma Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange Orient Pharma Co., Ltd. stocks are traded under the ticker 4166.
4166 stock has risen by 0.82% compared to the previous week, the last month showed zero change in price, over the last year Orient Pharma Co., Ltd. has showed a −35.12% decrease.
We've gathered analysts' opinions on Orient Pharma Co., Ltd. future price: according to them, 4166 price has a max estimate of 29.00 TWD and a min estimate of 29.00 TWD. Watch 4166 chart and read a more detailed Orient Pharma Co., Ltd. stock forecast: see what analysts think of Orient Pharma Co., Ltd. and suggest that you do with its stocks.
4166 reached its all-time high on Oct 31, 2013 with the price of 142.10 TWD, and its all-time low was 11.55 TWD and was reached on Mar 23, 2020. View more price dynamics on 4166 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4166 stock is 2.92% volatile and has beta coefficient of 0.80. Track Orient Pharma Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Orient Pharma Co., Ltd. there?
Today Orient Pharma Co., Ltd. has the market capitalization of 6.00 B, it has increased by 3.14% over the last week.
Yes, you can track Orient Pharma Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Orient Pharma Co., Ltd. is going to release the next earnings report on Mar 30, 2026. Keep track of upcoming events with our Earnings Calendar.
4166 net income for the last quarter is 47.26 M TWD, while the quarter before that showed 18.77 M TWD of net income which accounts for 151.75% change. Track more Orient Pharma Co., Ltd. financial stats to get the full picture.
No, 4166 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4166 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Orient Pharma Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Orient Pharma Co., Ltd. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Orient Pharma Co., Ltd. stock shows the sell signal. See more of Orient Pharma Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.